Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Prasugrel: Suspended Phase II enrollment

LLY suspended enrollment in a pair of Phase II trials of prasugrel based on preliminary pharmacokinetic data that

Read the full 187 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE